CN1622827A - 促进心脏组织修复的凝血酶衍生肽 - Google Patents
促进心脏组织修复的凝血酶衍生肽 Download PDFInfo
- Publication number
- CN1622827A CN1622827A CNA028285697A CN02828569A CN1622827A CN 1622827 A CN1622827 A CN 1622827A CN A028285697 A CNA028285697 A CN A028285697A CN 02828569 A CN02828569 A CN 02828569A CN 1622827 A CN1622827 A CN 1622827A
- Authority
- CN
- China
- Prior art keywords
- gly
- asp
- ala
- angiogenesis
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
方法 | 单个最大值 | 平均损伤厚度 | 所有切片平均值 | ||||||
测量的面积 | 已处理 | 对照 | 差值 | 已处理 | 对照 | 差值 | 已处理 | 对照 | 差值 |
新内膜 | .202 | .332 | -39%* | .158 | .245 | -36% | .117 | .185 | -37%* |
介质 | .113 | .133 | -15% | .123 | .152 | -19% | .116 | .140 | -17% |
新内膜+介质/未损伤的介质 | 4.56 | 7.73 | -41%* | 4.18 | 5.87 | -29%* | 3.49 | 5.55 | -37%* |
配方 | 聚乳酸∶聚乙醇酸 | 聚合物分子量 | %TP508 | %聚乙二醇 |
A | 50∶50 | 46,700 | 5 | 0 |
B | 50∶50 | 7,200 | 5 | 0 |
C | 50∶50 | 46,700 | 5 | 5 |
D | 50∶50 | 46,700 | 5 | 0 |
E | 75∶25 | 120,000 | 5 | 0 |
配方 | 直径,微米 | TP508夹带,% |
A | 26.0 | 53.8 |
B | 16.2 | 27.1 |
C | 17.6 | 58.9 |
D | 23.9 | 42.6 |
E | 25.8 | 36.2 |
Claims (26)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/001396 WO2003061689A1 (en) | 2002-01-16 | 2002-01-16 | Thrombin derived peptides for promoting cardiac tissue repair |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1622827A true CN1622827A (zh) | 2005-06-01 |
CN100372567C CN100372567C (zh) | 2008-03-05 |
Family
ID=27608965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028285697A Expired - Fee Related CN100372567C (zh) | 2002-01-16 | 2002-01-16 | 促进心脏组织修复的凝血酶衍生肽 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1467749B1 (zh) |
JP (1) | JP4205592B2 (zh) |
CN (1) | CN100372567C (zh) |
AT (1) | ATE504311T1 (zh) |
CA (1) | CA2511223A1 (zh) |
DE (1) | DE60239705D1 (zh) |
ES (1) | ES2395275T3 (zh) |
HK (1) | HK1078263A1 (zh) |
WO (1) | WO2003061689A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102250253A (zh) * | 2010-05-17 | 2011-11-23 | 中国人民解放军军事医学科学院军事兽医研究所 | 一种含凝血酶片段融合肽 |
TWI486168B (zh) * | 2006-09-22 | 2015-06-01 | Univ Texas | 治療內皮功能不良之方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090232866A1 (en) * | 2003-10-07 | 2009-09-17 | Mariann Pavone-Gyongyosi | Oligopeptides as coating material for medical products |
EP1559431B1 (en) | 2003-12-31 | 2007-03-28 | Orthologic Corp. | Pharmaceutical composition for thrombin peptide derivatives |
WO2009142679A2 (en) * | 2008-03-26 | 2009-11-26 | Orthologic Corp. | Methods for treating acute myocardial infarction |
US10220078B2 (en) | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352664A (en) * | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
TWI257307B (en) * | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
-
2002
- 2002-01-16 CA CA002511223A patent/CA2511223A1/en not_active Abandoned
- 2002-01-16 DE DE60239705T patent/DE60239705D1/de not_active Expired - Lifetime
- 2002-01-16 EP EP02707514A patent/EP1467749B1/en not_active Expired - Lifetime
- 2002-01-16 CN CNB028285697A patent/CN100372567C/zh not_active Expired - Fee Related
- 2002-01-16 ES ES02707514T patent/ES2395275T3/es not_active Expired - Lifetime
- 2002-01-16 AT AT02707514T patent/ATE504311T1/de not_active IP Right Cessation
- 2002-01-16 JP JP2003561632A patent/JP4205592B2/ja not_active Expired - Fee Related
- 2002-01-16 WO PCT/US2002/001396 patent/WO2003061689A1/en active Application Filing
-
2005
- 2005-11-14 HK HK05110180A patent/HK1078263A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI486168B (zh) * | 2006-09-22 | 2015-06-01 | Univ Texas | 治療內皮功能不良之方法 |
CN102250253A (zh) * | 2010-05-17 | 2011-11-23 | 中国人民解放军军事医学科学院军事兽医研究所 | 一种含凝血酶片段融合肽 |
Also Published As
Publication number | Publication date |
---|---|
ES2395275T3 (es) | 2013-02-11 |
ATE504311T1 (de) | 2011-04-15 |
EP1467749B1 (en) | 2011-04-06 |
CN100372567C (zh) | 2008-03-05 |
WO2003061689A1 (en) | 2003-07-31 |
JP2005519066A (ja) | 2005-06-30 |
JP4205592B2 (ja) | 2009-01-07 |
DE60239705D1 (de) | 2011-05-19 |
EP1467749A1 (en) | 2004-10-20 |
HK1078263A1 (en) | 2006-03-10 |
CA2511223A1 (en) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100500211C (zh) | 用凝血酶派生的肽的治疗方法 | |
CN1165294C (zh) | 具有多层结构的控释制剂 | |
CN1133464C (zh) | 控制释放可溶性受体的药物组合物 | |
ES2200375T3 (es) | Metodos para fabricar preparaciones de liberacion controlada basadas en polimero. | |
Jay et al. | Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation | |
CN1527698A (zh) | 控释可生物降解的凝胶基质 | |
CN101951892A (zh) | 使用氯压定和布比卡因治疗手术后疼痛的组合物和方法 | |
JPH05286850A (ja) | 放出を制御されたインプラントに使用する液状混合物、インプラントに好適なポリマーシステム及びそのポリマーシステムを用いた治療方法 | |
CN101842099A (zh) | 包括局部麻醉药的治疗术后痛的方法和组合物 | |
CN1458974A (zh) | 用非蛋白质水解激活的凝血酶受体的激动剂刺激软骨生长 | |
EA004943B1 (ru) | Суспензия биоразлагаемых микросфер и способ лечения глиобластомы | |
JP3187410B2 (ja) | 脳内投与用徐放性製剤 | |
CN107260684A (zh) | 用于在局部给药位点改进药物组合物的滞留的组合物和方法 | |
CN100372567C (zh) | 促进心脏组织修复的凝血酶衍生肽 | |
JP2001122800A (ja) | 骨シアロプロティンを含む結合組織修復促進組成物及び骨シアロプロティンの使用方法 | |
CN1882350A (zh) | 控制动物中血管发生的方法 | |
CN101204365A (zh) | 一种治疗实体肿瘤的植入剂 | |
RU2527701C1 (ru) | Способ приготовления средства, обладающего свойством стимуляции регенерации хрящевой, костной, мышечной тканей и способ стимуляции регенерации хрящевой, костной, мышечной тканей с использованием приготовленного средства | |
US20200222531A1 (en) | Methods of populating precipitated particles of a modified or synthesized substance in a tissue | |
CN102872450A (zh) | 一种用于复合给药的组合物 | |
CN100563645C (zh) | 一种治疗实体肿瘤的蓓萨罗丁缓释植入剂 | |
CN1290576C (zh) | 胸腺素β15在制备促进伤口愈合及血管生成的物质中的用途 | |
JPS6097918A (ja) | インタ−フエロン持続性製剤 | |
CN101204369A (zh) | 一种治疗实体肿瘤的索非拉尼缓释植入剂 | |
Karacaoğlu et al. | Effect of long‐term application of epinephrine on rat skin vasculature: Experimental study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: OSOLUGIAIS CO., LTD. Free format text: FORMER OWNER: THE BOARD OF REGENTS, THE UNIV. OF TEXAS SYSTEM Effective date: 20051223 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20051223 Address after: Arizona, USA Applicant after: Orthologic Corp. Address before: American Texas Applicant before: Board of Regents of the Univ. of Texas System |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1078263 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1078263 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080305 Termination date: 20130116 |
|
CF01 | Termination of patent right due to non-payment of annual fee |